CARMEL, Ind., Feb. 15, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, invites entries into the inaugural Syra Health Mental and Behavioral Health Solutions Award. This initiative awards $5,000 to one national advocacy group that is destigmatizing mental health and prioritizing mental wellness to diverse audiences, in an attempt to help address the nation's mental health crises.
CRITERIA:
An impartial panel of mental and behavioral health experts will assess award entries based on the following criteria:
To be eligible, any advocacy group submitting an entry must be a national 501(c)(3) nonprofit organization in good standing.
IMPORTANT DATES:
Syra Health plans to announce the winner of the award during a May 2, 2024, event coinciding with national Mental Health Awareness Month. The Syra Health Mental and Behavioral Health Solutions Award underscores Syra Health's dedication to changing the nation's mental and behavioral health landscape by focusing on solutions including the company's own novel Syrenity app. Syrenity focuses on preventing mental health crises before they occur by providing an AI-backed diary for continual monitoring of mood. Should treatment be required, Syrenity integrates with telehealth to connect users with licensed therapists in less than 48 hours. Syra Health is also committed to seeing mental and behavioral health checkups occur annually, the same as yearly physicals.
Sandeep Allam, Executive Chairman and President, Syra Health, emphasizes the importance of the award, stating, "We believe in recognizing and supporting the impactful work of advocacy groups in the mental and behavioral health space. By launching the Syra Health Mental and Behavioral Health Solutions Award, we aim to foster positive change and contribute to the collective efforts in addressing crucial aspects of mental health on a national scale."
Syra Health encourages all eligible national advocacy groups to participate in the award and share their impactful mental and behavioral health initiatives.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors outlined in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications & Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701 This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.94 |
Daily Change: | -0.06 -5.86 |
Daily Volume: | 138,116 |
Market Cap: | US$6.220M |
August 08, 2024 July 30, 2024 May 14, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB